![Warren Weeks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Warren Weeks
Geen lopende functies
Profiel
Warren Weeks is the founder of Nitronex LLC, which was founded in 1999.
He worked as a Principal at Wolfspeed, Inc. and Cree Dulles, Inc. He was also a Vice President-Product Development at Selah Technologies LLC from 2008 to 2013.
Mr. Weeks received his undergraduate degree from Clemson University and his graduate degree from North Carolina State University.
Eerdere bekende functies van Warren Weeks
Bedrijven | Functie | Einde |
---|---|---|
Selah Technologies LLC
![]() Selah Technologies LLC Pharmaceuticals: MajorHealth Technology Selah Technologies, LLC is an advanced materials manufacturing company developing and commercializing two proprietary nano technologies. Selah Dots are patent-pending photo luminescent carbon-based nano particles. Selah Tubes™ are enriched single-walled nanotubes with precisely engineered electronic properties protected under U.S. Patent No. 7,374,685. Its growth strategy is to leverage relationships with market leading companies to establish mutually beneficial joint research and development agreements. The company strategy is founded in the conviction that early successes in its target markets will occur via exploitation of nanomaterials in established applications in which their incorporation is both useful and compelling, and addresses needs that nanotechnology can fulfill either immediately or in the very short term. | Corporate Officer/Principal | 18-04-2013 |
Nitronex LLC
![]() Nitronex LLC Electronic ComponentsElectronic Technology Nitronex LLC develops and manufactures a wide range of GaN-on-Si RF power transistors and Monolithic Microwave Integrated Circuit for commercial and military markets. The company was founded by Warren Weeks, Thomas Gehrke, Kvin J. Linthicum. And Johnson Mark on September 19, 2012 and is headquartered in Durham, NC. | Oprichter | - |
WOLFSPEED, INC. | Corporate Officer/Principal | - |
Cree Dulles, Inc.
![]() Cree Dulles, Inc. SemiconductorsElectronic Technology Part of Wolfspeed, Inc., Cree Dulles, Inc. is a company that manufactures insulating and conductive silicon carbide wafers. The company is based in Sterling, VA. Cree Dulles was acquired by Wolfspeed, Inc. on July 10, 2006 for $46 million. | Corporate Officer/Principal | - |
Opleiding van Warren Weeks
Clemson University | Undergraduate Degree |
North Carolina State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WOLFSPEED, INC. | Electronic Technology |
Bedrijven in privébezit | 3 |
---|---|
Nitronex LLC
![]() Nitronex LLC Electronic ComponentsElectronic Technology Nitronex LLC develops and manufactures a wide range of GaN-on-Si RF power transistors and Monolithic Microwave Integrated Circuit for commercial and military markets. The company was founded by Warren Weeks, Thomas Gehrke, Kvin J. Linthicum. And Johnson Mark on September 19, 2012 and is headquartered in Durham, NC. | Electronic Technology |
Cree Dulles, Inc.
![]() Cree Dulles, Inc. SemiconductorsElectronic Technology Part of Wolfspeed, Inc., Cree Dulles, Inc. is a company that manufactures insulating and conductive silicon carbide wafers. The company is based in Sterling, VA. Cree Dulles was acquired by Wolfspeed, Inc. on July 10, 2006 for $46 million. | Electronic Technology |
Selah Technologies LLC
![]() Selah Technologies LLC Pharmaceuticals: MajorHealth Technology Selah Technologies, LLC is an advanced materials manufacturing company developing and commercializing two proprietary nano technologies. Selah Dots are patent-pending photo luminescent carbon-based nano particles. Selah Tubes™ are enriched single-walled nanotubes with precisely engineered electronic properties protected under U.S. Patent No. 7,374,685. Its growth strategy is to leverage relationships with market leading companies to establish mutually beneficial joint research and development agreements. The company strategy is founded in the conviction that early successes in its target markets will occur via exploitation of nanomaterials in established applications in which their incorporation is both useful and compelling, and addresses needs that nanotechnology can fulfill either immediately or in the very short term. | Health Technology |